Core Insights - Zacks Premium offers various tools for investors to enhance their stock market strategies, including daily updates on Zacks Rank and Industry Rank, access to the Zacks 1 Rank List, Equity Research reports, and Premium stock screens [1] Zacks Style Scores - Zacks Style Scores are indicators designed to help investors select stocks with the highest potential to outperform the market within 30 days, rated from A to F based on value, growth, and momentum characteristics [2] - The Value Score focuses on identifying undervalued stocks using financial ratios like P/E, PEG, and Price/Sales to find attractive investment opportunities [3] - The Growth Score assesses a company's financial health and future outlook by analyzing projected and historical earnings, sales, and cash flow to identify stocks with sustainable growth potential [4] - The Momentum Score identifies optimal times to invest based on price trends and earnings estimate changes, emphasizing the importance of following market trends [5] - The VGM Score combines all three Style Scores, providing a comprehensive indicator for investors who utilize multiple investment strategies [6] Zacks Rank and Style Scores Integration - The Zacks Rank is a proprietary model that leverages earnings estimate revisions to assist investors in building successful portfolios, with 1 (Strong Buy) stocks achieving an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [7][8] - To maximize returns, investors should focus on stocks with a Zacks Rank of 1 or 2 that also have Style Scores of A or B, while stocks with a 3 (Hold) rank should also possess high Style Scores to ensure potential upside [9][10] Company Spotlight: Universal Health Services (UHS) - Universal Health Services Inc. operates various healthcare facilities and currently holds a 3 (Hold) rating on the Zacks Rank, with a VGM Score of A and a Momentum Style Score of B, indicating potential for growth [11] - Recent analyst revisions have positively impacted UHS's earnings estimates for fiscal 2025, with the Zacks Consensus Estimate rising by $0.19 to $19.43 per share, alongside an average earnings surprise of 13.8% [12]

Summary of Universal Health Services (UHS) FY Conference Call - June 09, 2025 Company Overview - **Company**: Universal Health Services (UHS) - **Industry**: Healthcare, specifically acute care and behavioral health services Key Points Industry and Market Dynamics - 2024 is viewed as a transition year post-COVID, with 2025 expected to be the first full post-COVID year [2] - Acute care metrics are returning to pre-COVID levels, with mid-single-digit revenue growth projected at around 6% [3] - Adjusted admission growth is expected to be between 2.5% to 3.5%, with pricing growth contributing similarly [3] - The industry is experiencing a catch-up in procedures that were postponed during the pandemic, leading to softer procedural volumes compared to previous years [4] Financial Performance - Revenue growth is described as sustainable, with well-controlled expenses leading to increasing EBITDA and margins [7] - Wage inflation has decelerated, and the use of temporary labor has significantly reduced, contributing to better expense management [6] - The company aims to return acute care margins to pre-pandemic levels within the next 18 to 24 months [32] Operational Insights - Length of stay for patients remains above pre-COVID levels, with opportunities to reduce it further, primarily hindered by challenges in discharging patients to subacute settings [10][12] - The company is actively working on partnerships with subacute providers to improve patient discharge processes [17] Growth and Expansion - UHS is in a period of expansion, adding approximately 300 beds in 2025 and another 300 in 2026, which is expected to contribute to future admissions growth [18][19] - New hospitals typically take 18 to 24 months to ramp up to divisional average performance, with some exceptions in high-demand areas like Las Vegas [20][21] Pricing and Revenue Outlook - Contractual pricing is stable, with annual increases in the 4% to 5% range, although payer behavior regarding denials and nonpayment remains a concern [27][28] - The company anticipates a return to pre-COVID margins of 16% to 16.5% in the acute care segment within the next 18 to 24 months [30] Behavioral Health Segment - The behavioral health business is expected to achieve a volume growth trajectory of 2% to 3%, supported by increasing demand for mental health services [33] - Labor shortages have impacted the ability to meet patient needs, but improvements are anticipated as staffing levels stabilize [34] - The company is expanding its outpatient services to capture a larger share of the growing demand in behavioral health [39] Future Considerations - The company is cautious about the sustainability of high pricing levels in the behavioral health market, anticipating a potential moderation as volumes increase [48] - EBITDA margins in the behavioral segment are currently at the upper end of historical ranges, with room for further expansion if revenue growth continues [52] Regulatory Environment - Ongoing discussions regarding the DPP (Direct Payment Program) and its implications for reimbursement rates are being monitored closely [56][57] Financial Projections - The company estimates a potential impact of $95 million from changes in ACA subsidies, reflecting the uncertainty in the regulatory landscape [59] This summary encapsulates the key insights and projections discussed during the UHS FY Conference Call, highlighting the company's strategic focus on recovery, growth, and operational efficiency in the post-COVID landscape.

Core Viewpoint - Universal Health Services (UHS) shares have increased by approximately 12% over the past month, outperforming the S&P 500, raising questions about the sustainability of this trend leading up to the next earnings release [1] Estimates Movement - Estimates for Universal Health Services have trended upward over the past month, indicating positive sentiment among analysts [2] VGM Scores - Universal Health Services currently holds a strong Growth Score of A, a Momentum Score of B, and a Value Score of A, placing it in the top 20% for the value investment strategy, resulting in an aggregate VGM Score of A [3] Outlook - The upward trend in estimates suggests a promising outlook for Universal Health Services, which currently has a Zacks Rank of 3 (Hold), indicating expectations for an in-line return in the coming months [4] Industry Performance - Universal Health Services is part of the Zacks Medical - Hospital industry, where HCA Healthcare has gained 11.2% over the past month, reporting revenues of $18.32 billion for the last quarter, reflecting a year-over-year increase of 5.7% [5] - HCA is projected to report earnings of $6.20 per share for the current quarter, representing a year-over-year change of 12.7%, with the Zacks Consensus Estimate remaining unchanged over the last 30 days, also holding a Zacks Rank of 3 (Hold) and a VGM Score of A [6]

Summary of Universal Health Services (UHS) 2025 Conference Call Industry Overview - The discussion primarily revolves around the healthcare services industry, specifically focusing on Medicaid policy changes and their implications for Universal Health Services (UHS) [3][4][5]. Key Points and Arguments 1. **Medicaid Policy Changes**: - The potential negative impacts of the new house bill on Medicaid are perceived to be less severe than initially feared, particularly regarding work requirements aimed at younger, healthier males [3][4]. - The existing direct payment programs (DPP) are expected to face limitations in growth, but UHS anticipates minimal impact on current cash flows from these programs [4][5]. 2. **State-Level Support for DPP**: - States like Florida, Texas, and Mississippi are expected to lobby for the continuation of DPP programs, indicating a strong state-level support that may mitigate deeper cuts [5]. 3. **Tennessee and D.C. Programs**: - The Tennessee Medicaid program is likely to be grandfathered under the new bill, while the D.C. program remains uncertain regarding its approval timeline [6][7]. 4. **Volume and Revenue Growth**: - UHS targets a same-store growth rate of 5-7% for acute care, with expectations of achieving this through a balance of price and volume growth [12][25]. - Behavioral health volumes are expected to ramp up later in the year, with a target of 2.5-3% patient day growth [14][15]. 5. **Pricing Trends in Behavioral Health**: - Strong pricing trends in behavioral health are noted, attributed to limited capacity and labor shortages, allowing UHS to negotiate better rates with payers [17][18]. 6. **Referral Relationships**: - UHS maintains strong referral relationships, which are crucial for sustaining demand in behavioral health despite increased competition [20]. 7. **Bipartisan Support for Behavioral Health**: - There is continued bipartisan support for expanding access to behavioral health care, with a focus on outpatient care [21][22][23]. 8. **Capital Expenditure (CapEx)**: - UHS plans to allocate a significant portion of its $240 million CapEx for new hospital projects, including facilities in Florida and California [31][32]. 9. **Performance of New Facilities**: - The West Henderson hospital achieved EBITDA positivity in its first full quarter, indicating a strong ramp-up compared to typical new hospital performance [35][36]. 10. **Cost Management**: - Professional fees are expected to rise by about 5% due to inflation, with specific pressures noted from emergency room physicians and anesthesiologists [42][43]. Additional Important Content - The impact of tariffs on supply costs appears to be minimal in the short term, with UHS managing supply chain dynamics effectively [27][28]. - Staffing challenges at new facilities are acknowledged, but UHS has experience in managing these dynamics without significant disruption [39][40]. This summary encapsulates the key insights and discussions from the Universal Health Services conference call, highlighting the company's strategic outlook and operational performance within the healthcare services industry.

Universal Health Services (UHS) FY 2025 Annual General Meeting May 14, 2025 10:00 AM ET Speaker0 Hello and welcome to the Annual Meeting of Stockholders of Universal Health Services Inc. Please note that today's meeting is being recorded. After the formal meeting has adjourned, we'll have a question and answer session. Any stockholders logged into the virtual meeting web portal using their 15 digit control number can submit questions or comments at any time by clicking on the Q and A tab. Out of considerati ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-10765 UNIVERSAL HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) DELAWARE 23-2077891 (State or other j ...

Group 1 - Universal Health Services (UHS) has been upgraded to a Zacks Rank 2 (Buy), indicating an upward trend in earnings estimates which significantly impacts stock prices [1][3] - The Zacks rating system is based on changes in earnings estimates, which are tracked through a consensus measure from sell-side analysts [1][6] - Rising earnings estimates suggest an improvement in the underlying business of Universal Health Services, which could lead to higher stock prices [5][10] Group 2 - For the fiscal year ending December 2025, Universal Health Services is expected to earn $18.99 per share, reflecting a 14.3% increase from the previous year [8] - Over the past three months, the Zacks Consensus Estimate for Universal Health Services has increased by 8.5% [8] - The Zacks Rank system maintains a balanced distribution of ratings, with only the top 20% of stocks receiving a 'Strong Buy' or 'Buy' rating, indicating superior earnings estimate revisions [9][10]

Core Viewpoint - Universal Health Services (UHS) shares have increased by 2.4% recently, closing at $178.74, with a potential upside of 26.3% based on Wall Street analysts' mean price target of $225.81 [1] Price Targets - The average of 16 short-term price targets ranges from a low of $198 to a high of $280, with a standard deviation of $21.94, indicating variability among analysts [2] - The lowest estimate suggests a 10.8% increase from the current price, while the highest estimate indicates a 56.7% upside [2] Analyst Sentiment - Analysts show a consensus that UHS will report better earnings than previously estimated, which historically correlates with stock price increases [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 0.3%, with four estimates moving higher and one lower [12] Zacks Rank - UHS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential for upside [13]

Financial Data and Key Metrics Changes - The company reported net income attributable to UHS per diluted share of $4.8 for Q1 2025, with adjusted net income per diluted share at $4.84 [4] - Adjusted admissions to acute care hospitals increased by 2.4% year-over-year [4] - Same facility net revenues in the Acute Care Hospital segment increased by 5% compared to Q1 2024 [5] - EBITDA increased by 21% after excluding Medicaid supplemental payments [5] - Cash generated from operating activities decreased to $360 million from $396 million in Q1 2024 due to delays in Medicaid payments [6] Business Line Data and Key Metrics Changes - Same facility net revenues at behavioral health hospitals increased by 5.5%, driven by a 5.8% increase in revenue per adjusted day [5] - Adjusted patient days were relatively flat compared to the prior year, impacted by the leap day in 2024 and adverse weather conditions [6] Market Data and Key Metrics Changes - The company experienced a reacceleration of patient day growth in March 2025 [6] - The Nevada supplemental program received $82 million in payments in April, related to Q1 revenues [6] Company Strategy and Development Direction - The company is focused on managing operating expenses effectively across both business segments [8] - The opening of new facilities, such as West Henderson Hospital, is expected to contribute positively to EBITDA [10] - The company reiterated its full-year earnings guidance despite uncertainties in the external operating environment [11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in underlying business performance despite external uncertainties [11] - The company anticipates achieving a behavioral patient day revenue growth target of 2.5% to 3% for the year [15] - Management acknowledged ongoing challenges in labor markets but noted improvements in staffing levels [78] Other Important Information - The company spent $239 million on capital expenditures in Q1 2025 and repurchased $1 million of its own shares [7] - The company has $1.02 billion of available borrowing capacity under its revolving credit facility [7] Q&A Session Summary Question: Insights on behavioral health volumes and future guidance - Management confirmed that the full-year guidance of 2.5% to 3% patient day revenue growth remains reasonable despite a slow start in Q1 [15][20] Question: Updates on Medicaid supplemental payment programs - Management indicated that approvals for Tennessee and D.C. programs are expected, but timing remains uncertain [16][17] Question: Impact of tariffs on supply chain - Management noted that approximately 75% of supply chain purchases are insulated from tariffs, and they are monitoring vendor responses [26][28] Question: Trends in acute business and acuity - Management reported that acuity was muted in Q1 due to a busy flu season but expects normalization as the year progresses [62] Question: Expense management and premium labor costs - Premium pay costs were consistent at $63 million, and management is optimistic about sustaining operating expense controls [70][72] Question: Updates on commercial rate negotiations - Management stated that overall guidance for acute care revenue growth remains at 5% to 6%, with no significant impact from payer behavior noted [105][106]

Universal Health Services (UHS) Q1 2025 Earnings Call April 29, 2025 09:00 AM ET Company Participants Steve Filton - Executive VP, CFO & SecretaryMarc Miller - CEO, President & DirectorAndrew Mok - DirectorBen Hendrix - Vice PresidentBenjamin Rossi - Equity Research AssociateJoshua Raskin - Partner - Managed Care & ProvidersCraig Hettenbach - Executive DirectorA.J. Rice - Managing Director Conference Call Participants Justin Lake - Analyst - Healthcare ServicesSarah James - Managing Director & Equity Analys ...